Protein therapeutics like insulin and GLP-1 inhibitors have a problem. They tend to aggregate when heated or shaken, robbing them of their potency. Researchers have now developed a ...
Bioprocessors must minimize the aggregation of therapeutic proteins, but that’s not an easy task. Proteins can aggregate during any step from manufacturing to administering a drug. “The aggregation ...
Scientists from the Karolinska Institute in Sweden and the Swedish University of Agricultural Sciences report that spider silk proteins can be fused to biologically active proteins and be converted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results